ASHLEY FUGATE: Open Payments
NPI 1104281583 · NILES, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 32 payments from 17 companies in 2025. Trend: 2023 $3,135 · 2024 $424 · 2025 $621
Food & beverage: $621
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $141 |
| ABBVIE INC. | 3 | $66 |
| Dexcom, Inc. | 3 | $53 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Lundbeck LLC | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $21 |
Products named: Rybelsus, REXULTI, Dexcom G6 Transmitter, TRELEGY ELLIPTA, QULIPTA, Auvelity, VAXNEUVANCE, VRAYLAR.
Industry payments across MI — which companies pay providers there.
